Option Care Health’s plan to buy home care giant Amedisys for $3.6 billion continues a trend of providers, payers and retailers hoping to cash in on the lucrative market of baby boomers who increasingly prefer to get healthcare at home and age in place. The proposed merger between Option Care Health, the nation’s largest private home infusion provider, and Amedisys’ home health, hospital at home and palliative care businesses would create a single company with a broad array of in-home healthcare services across 46 states. Interest in home health and hospice from corporate buyers and private equity firms began heating up before the COVID-19 pandemic due to aging demographics. Patients and healthcare providers increasingly preferred in-home treatment to avoid possible transmission of the coronavirus.
Read the full article: What the Option Care Health-Amedisys Deal Says about Home Care //
Source: https://www.modernhealthcare.com/finance/option-care-health-amedisys-deal-post-acute-care